Log in to save to my catalogue

Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset modera...

Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset modera...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9352605

Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset moderate-to-severe luminal paediatric Crohn’s disease

About this item

Full title

Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset moderate-to-severe luminal paediatric Crohn’s disease

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

European journal of pediatrics, 2022-08, Vol.181 (8), p.3055-3065

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

To induce remission in luminal paediatric Crohn’s disease (CD), the ESPGHAN/ECCO guideline recommends treatment with exclusive enteral nutrition (EEN) or oral corticosteroids. In newly diagnosed moderate-to-severe paediatric CD patients, we determined the proportion of patients in which EEN or corticosteroids induced remission and maintained remiss...

Alternative Titles

Full title

Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset moderate-to-severe luminal paediatric Crohn’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9352605

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9352605

Other Identifiers

ISSN

1432-1076,0340-6199

E-ISSN

1432-1076

DOI

10.1007/s00431-022-04496-7

How to access this item